Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1348
| Despition | Presenilin 1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1290 | Insulin Receptor Blocking Peptide (AC1290) | 250 µg | inquiry |
| ACPP-1469 | Human S100A8 Protein (AC1469) | 5 µg | inquiry |
| ACPP-1170 | GAPDH Blocking Peptide (AC1170) | 250 µg | inquiry |
| ACPP-1054 | Recombinant Human Neuroglycan C Protein (6×His Tag) (AC1054) | 50 µg | inquiry |
| ACPP-1549 | Human VEGF C Protein (AC1549) | 2 µg | inquiry |
| ACPP-1728 | Human Human C Peptide (Active) Protein (AC1728) | 100 µg | inquiry |
| ACPP-1606 | Human GAD2 Protein (AC1606) | 50 µg | inquiry |
| ACPP-1324 | Insulin Receptor Blocking Peptide (AC1324) | 250 µg | inquiry |
| ACPP-1735 | Human BEST1 Protein (AC1735) | 5 µg | inquiry |
| ACPP-1821 | Human NT 4 Protein (AC1821) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.